NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.1480
+0.0440 (42.31%)
Nov 20, 2026, 3:57 PM EST
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $28.28 million as of November 20, 2026. It is the 33,798th most valuable company in the world and the 4,882nd biggest in the United States. Its market cap has decreased by 86.83% in one year.
Market Cap
28.28M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#4,882 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 28.28M, an increase of 924.82%. That is a compound annual growth rate of 16.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 28.28M | -89.27% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 29.57M |
| ZIVO Bioscience | 22.83M |
| EOM Pharmaceuticals Holdings | 19.99M |
| Provectus Biopharmaceuticals | 18.20M |
| Biomind Labs | 16.70M |
| Vicapsys Life Sciences | 16.19M |
| Inhibitor Therapeutics | 13.90M |
| Synlogic | 13.47M |